Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

Blood

Volumn 99, Issue 10, 2002, Pages 3661-3667

  Costello, Régis T ^a,b,c   Sivori, Simona ^a,b,c   Marcenaro, Emanuela ^a,b,c   Lafage Pochitaloff, Marina ^a,b,c   Mozziconacci, Marie Joelle ^a,b,c   Reviron, Denis ^a,b,c   Gastaut, Jean Albert ^a,b,c   Pende, Daniela ^a,b,c   Olive, Daniel ^a,b,c   Moretta, Alessandro ^a,b,c  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL CYTOTOXICITY RECEPTOR; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL;

EID: 0037093066     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.10.3661     Document Type: Article

References (40)

1. Receptors for HLA class-I molecules in human natural killer cells
2. Regulation of immune response through inhibitory receptors
3. The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles
4. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
5. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
6. Natural cytotoxicity receptors that trigger human NK-mediated cytolysis
7. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells
8. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
9. An activating immunoreceptor complex formed by NKG2D and DAP10
10. Murine NKG2d and CD94 are clustered within the natural killer complex and are expressed independently in natural killer cells
11. Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of non-epithelia origin
12. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
13. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
14. HLA class I antigen downregulation in human cancers; T-cell immunotherapy revives an old story
15. Altered MHC class I antigens in tumors
16. HLA class I antigens on normal and leukemic cells (quantitative analysis)
17. Expression of class I and class II markers on populations of leukemic cells
18. Deficient expression of class-I HLA in some cases of acute leukemia
19. Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: A model study
20. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation
21. The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation
22. Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation
23. Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice
24. The role of natural killer cells in the treatment of chronic myelold leukemia
25. Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets
26. Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture
27. +dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis
28. Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha
29. BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells
30. Natural killer cell activity and cytokine production as prognostic factors in adult acute leukemia
31. Natural killer cells adhere to bone marrow fibroblasts and inhibit adhesion of acute myeloid leukemia cells
32. Role of natural effector cells in the prevention of radiation-induced leukemogenesis
33. Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses
34. HTLV-1 gene expression in adult T-cell leukemia cells elicits an NK cell response in vitro and correlates with cell rejection in SCID mice
35. Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia
36. Variable expression of CD3-zeta and associated protein tyrosine kinases in lymphocytes from patients with myeloid malignancies
37. T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28
38. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
39. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the disease
40. Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity